These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6112153

  • 21. Characterization of solubilized dopamine receptors from dog striatum.
    Gorissen H, Aerts G, Laduron P.
    FEBS Lett; 1979 Apr 15; 100(2):281-5. PubMed ID: 37113
    [No Abstract] [Full Text] [Related]

  • 22. Neuroleptics have identical potencies in human brain limbic and putamen regions.
    Seeman P, Ulpian C.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):145-8. PubMed ID: 6140171
    [Abstract] [Full Text] [Related]

  • 23. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S, Briley MS, Dubocovich ML, Langer SZ.
    Life Sci; 1978 Oct 30; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract] [Full Text] [Related]

  • 24. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
    Gyüre K, Szentendrei T, Kanyicska B, Fekete MI, Rónai AZ.
    Pol J Pharmacol Pharm; 1985 Oct 30; 37(3):253-61. PubMed ID: 2866498
    [Abstract] [Full Text] [Related]

  • 25. Characteristics of [3H]sultopride binding to rat brain.
    Mizuchi A, Kitagawa N, Saruta S, Miyachi Y.
    Eur J Pharmacol; 1982 Oct 15; 84(1-2):51-9. PubMed ID: 6128237
    [Abstract] [Full Text] [Related]

  • 26. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM, Krstich M, McDonald D, Gundlach AL.
    Neurosci Lett; 1982 Apr 16; 29(2):147-51. PubMed ID: 6123968
    [Abstract] [Full Text] [Related]

  • 27. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS, Runice C.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):25-31. PubMed ID: 2865162
    [Abstract] [Full Text] [Related]

  • 28. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR, Dubocovich ML.
    J Pharmacol Exp Ther; 1983 Dec 08; 227(3):592-9. PubMed ID: 6655559
    [Abstract] [Full Text] [Related]

  • 29. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep 08; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 30. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
    Valchár M, Dobrovský K, Krejcí I, Dlabac A.
    Act Nerv Super (Praha); 1989 Apr 08; 31(1):77-9. PubMed ID: 2675526
    [No Abstract] [Full Text] [Related]

  • 31. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M, Hall JM, Frankham PA, Strange PG.
    J Neurochem; 1984 Oct 08; 43(4):926-34. PubMed ID: 6470714
    [Abstract] [Full Text] [Related]

  • 32. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T, Seeman P.
    Am J Psychiatry; 1980 Feb 08; 137(2):191-7. PubMed ID: 6101525
    [Abstract] [Full Text] [Related]

  • 33. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 34. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR, Dvorkin B, Klein PN, Makman MH.
    Brain Res; 1982 Mar 04; 235(1):205-11. PubMed ID: 6145486
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 04; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 39. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Mar 31; 407(2):253-62. PubMed ID: 2952221
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.